[go: up one dir, main page]

NO20055695L - Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer - Google Patents

Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer

Info

Publication number
NO20055695L
NO20055695L NO20055695A NO20055695A NO20055695L NO 20055695 L NO20055695 L NO 20055695L NO 20055695 A NO20055695 A NO 20055695A NO 20055695 A NO20055695 A NO 20055695A NO 20055695 L NO20055695 L NO 20055695L
Authority
NO
Norway
Prior art keywords
branched
linear
compounds
alkyl group
hydrogen atom
Prior art date
Application number
NO20055695A
Other languages
English (en)
Norwegian (no)
Inventor
Bernard Pirotte
Pascal De Tullio
Pierre Renard
Pierre Lestage
Daniel-Henri Caignard
Pierre Francotte
Laurence Danober
Emmanuel Graindorge
Stephane Boverie
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20055695L publication Critical patent/NO20055695L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20055695A 2003-05-05 2005-12-01 Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer NO20055695L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305448A FR2854634B1 (fr) 2003-05-05 2003-05-05 Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2004/001070 WO2004099217A1 (fr) 2003-05-05 2004-05-04 Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa

Publications (1)

Publication Number Publication Date
NO20055695L true NO20055695L (no) 2005-12-01

Family

ID=33306157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055695A NO20055695L (no) 2003-05-05 2005-12-01 Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer

Country Status (20)

Country Link
US (1) US7476668B2 (fr)
EP (1) EP1620441A1 (fr)
JP (1) JP4461139B2 (fr)
KR (1) KR100741235B1 (fr)
CN (1) CN100363368C (fr)
AR (1) AR044245A1 (fr)
AU (1) AU2004236005B2 (fr)
BR (1) BRPI0410002A (fr)
CA (1) CA2524377C (fr)
EA (1) EA009240B1 (fr)
FR (1) FR2854634B1 (fr)
GE (1) GEP20084318B (fr)
MA (1) MA27732A1 (fr)
MX (1) MXPA05011823A (fr)
MY (1) MY136694A (fr)
NO (1) NO20055695L (fr)
NZ (1) NZ543214A (fr)
UA (1) UA80046C2 (fr)
WO (1) WO2004099217A1 (fr)
ZA (1) ZA200508660B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005020462D1 (de) 2004-08-25 2010-05-20 Essentialis Inc Pharmazeutische formulierungen von kalium-atp-kanalöffnern und deren verwendungen
HRP20120005T1 (hr) 2006-01-05 2012-01-31 Essentialis Soli otvarača kalijskih kanala i njihova upotreba
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
CN103180326B (zh) 2010-08-10 2015-06-10 武田药品工业株式会社 杂环化合物及其用途
JP5901365B2 (ja) * 2012-03-12 2016-04-06 株式会社トクヤマ イミダート化合物の製造方法
EP3311842A1 (fr) 2013-06-13 2018-04-25 VeroScience LLC Compositions et procédés de traitement des troubles métaboliques
CN107922328B (zh) 2015-07-06 2020-05-19 公立大学法人横滨市立大学 和ampa受体特异性结合的新颖化合物
JP6241974B1 (ja) 2017-01-11 2017-12-06 公立大学法人横浜市立大学 霊長類生体の脳内ampa受容体のイメージング方法、プログラム、及びスクリーニング方法
US10680583B1 (en) * 2019-02-26 2020-06-09 Xilinx, Inc. Control circuit for and method of controlling an operation of an integrated circuit device
JOP20220063A1 (ar) 2019-09-16 2023-01-30 Takeda Pharmaceuticals Co مشتقات بيريدازين-3(2h)-أون ملتحمة بأزول

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3733409A (en) * 1969-05-20 1973-05-15 Schering Corp Method of treating hypertension using thieno (1,2,4) thiadiazines
WO1998012185A1 (fr) * 1996-09-17 1998-03-26 The Regents Of The University Of California Derives de benzothiadiazide et leur utilisation en tant que modulateurs positifs allosteriques du recepteur ampa
BR9810592A (pt) * 1997-07-16 2000-09-12 Novo Nordisk As Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2524377A1 (fr) 2004-11-18
ZA200508660B (en) 2007-01-31
HK1088327A1 (en) 2006-11-03
US20070004709A1 (en) 2007-01-04
CA2524377C (fr) 2010-08-24
UA80046C2 (en) 2007-08-10
AU2004236005A1 (en) 2004-11-18
AR044245A1 (es) 2005-09-07
AU2004236005B2 (en) 2010-01-21
WO2004099217A1 (fr) 2004-11-18
FR2854634B1 (fr) 2005-07-08
MXPA05011823A (es) 2006-05-25
BRPI0410002A (pt) 2006-04-25
CN1798750A (zh) 2006-07-05
JP2006525292A (ja) 2006-11-09
EP1620441A1 (fr) 2006-02-01
EA009240B1 (ru) 2007-12-28
FR2854634A1 (fr) 2004-11-12
NZ543214A (en) 2009-02-28
MA27732A1 (fr) 2006-01-02
US7476668B2 (en) 2009-01-13
EA200501696A1 (ru) 2006-06-30
JP4461139B2 (ja) 2010-05-12
GEP20084318B (en) 2008-03-10
CN100363368C (zh) 2008-01-23
MY136694A (en) 2008-11-28
KR20060006830A (ko) 2006-01-19
KR100741235B1 (ko) 2007-07-19

Similar Documents

Publication Publication Date Title
ECSP045359A (es) Isoxazolinas 5 metiloximetil sustituidas por 3-heteroarilo utilizadas con herbicidas
CA2565660A1 (fr) Composes aryl- ou heteroarylamides ortho-substitues
MY142807A (en) Benzimidazole derivative and use thereof.
WO2005105732A8 (fr) Composes methylaryl- ou heteroarylamides substitues
WO2008108386A1 (fr) Composition pharmaceutique
CA2536870A1 (fr) Composes de phenyle ou de pyridyle amide utiles comme antagonistes de la prostaglandine e2
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
NO20076006L (no) Acetylenderivater
EP1642880A4 (fr) Inhibiteur de proteines de la famille hsp90
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
NO20055695L (no) Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
HUP0303801A2 (hu) Heterociklusos alkoxi-, alkil-tio- és alkil-amino-benzazol-származékok, mint 5-hidroxi-triptamin-6 ligandumok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE377598T1 (de) Durch bicyclische aminogruppen substituierte verbindungen
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
MX2010008740A (es) Derivado de 3,8-diaminotetrahidroquinolina.
MY134226A (en) 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
ATE478884T1 (de) Oligosaccharidderivat
EP0798304A4 (fr) Medicament contre la thrombopenie
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav
JO2615B1 (en) Benzimidazole compound

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application